In industrialized countries, a high number of people suffer from arteriosclerosis – with fatal consequences: Deposits in the arteries lead to strokes and heart attacks. Researchers under the leadership of the University of Bonn have developed a method for guiding replacement cells to diseased vascular segments using nanoparticles. They demonstrated in mice that the fresh cells actually exert their curative effect in these segments. However, much research remains to be done prior to use in humans.
In arterial calcification (arteriosclerosis), pathological deposits form in the arteries and this leads to vascular stenosis. Strokes and heart attacks are a frequent outcome due to the resultant insufficient blood flow. Endothelial cells which line the blood vessels play an important role here. “They produce nitric oxide and also regulate the expansion of the vessels and the blood pressure,” explains junior professor Dr. med. Daniela Wenzel from the Institute of Physiology I of the University of Bonn. Damage to the endothelial cells is generally the insidious onset of arteriosclerosis.
A team of researchers working with Jun.-Prof. Wenzel, together with the Technische Universität München, the Institute of Pharmacology and Toxicology at the University of Bonn Hospital and the Physikalisch-Technische Bundesanstalt Berlin, developed a method with which damaged endothelial cells can regenerate and which they successfully tested in mice. The scientists transferred the gene for the enzyme eNOS into cultured cells with the aid of viruses. This enzyme stimulates nitic oxide production in the endothelium like a turboloader. “The enzyme is an essential precondition for the full restoration of the original function of the endothelial cells,” reports Dr. Sarah Vosen from Jun.-Prof. Wenzel’s team.
A magnet delivers the nanoparticles to the desired site
Together with the gene, the scientists also introduced tiny nanoparticles, measuring a few hundred nanometers (one-millionth of a millimeter), with an iron core. “The iron changes the properties of the endothelial cells: They become magnetic,” explains Dr. Sarah Rieck from the Institute of Physiology I of the University of Bonn. The nanoparticles ensure that the endothelial cells equipped with the “turbo” gene can be delivered to the desired site in the blood vessel using a magnet where they exert their curative effect. Researchers at the Technische Universität München have developed a special ring-shaped magnet configuration for this which ensures that the replacement cells equipped with nanoparticles line the blood vessel evenly.
The researchers tested this combination method in mice whose carotid artery endothelial cells were injured. They injected the replacement cells into the artery and were able to position them at the correct site using the magnet. “After half an hour, the endothelial cells adhered so securely to the vascular wall that they could no longer be flushed away by the bloodstream,” says Jun.-Prof. Wenzel. The scientists then removed the magnets and tested whether the fresh cells had fully regained their function. As desired, the new endothelial cells produced nitric oxide and thus expanded the vessel, as is usual in the case of healthy arteries. “The mouse woke up from the anesthesia and ate and drank normally,” reported the physiologist.
Transfer to humans requires additional research
Normally, doctors surgically remove vascular deposits from the carotid artery and in some cases place a vascular support (stent) to correct the bottleneck in the crucial blood supply. “However, these areas frequently become blocked with deposits once again,” reports Jun.-Prof. Wenzel. “In contrast, we are getting to the root of the problem and are restoring the original condition of healthy endothelial cells.” The researchers hope that what works in mice is also possible in humans, in principle. However, there are still many challenges to overcome. Jun.-Prof. Wenzel: “There is still a considerable need for research.”
The Latest on: Arteriosclerosis
via Google News
The Latest on: Arteriosclerosis
- AHA Issues New Advice on Managing Stage 1 Hypertensionon April 29, 2021 at 11:09 am
If lifestyle changes alone fail to lower slightly elevated blood pressure within 6 months, consider adding medication, the AHA says in a new scientific statement.
- If slightly high blood pressure doesn't respond to lifestyle change, medication can helpon April 29, 2021 at 2:02 am
the Council on Arteriosclerosis, Thrombosis and Vascular Biology; the Council on Cardiovascular Radiology and Intervention; the Council on Lifelong Congenital Heart Disease and Heart Health in the ...
- If slightly high blood pressure doesn’t respond to lifestyle change, medication can helpon April 29, 2021 at 1:14 am
Healthy lifestyle changes are the recommended treatment for people with stage 1 high blood pressure (130-139/80-89 mm Hg).
- ‘The legacy of Jallianwala Bagh is yet to be fully acknowledged … People feel excluded from the mainstream history’on April 27, 2021 at 8:26 am
The Jallianwala Bagh massacre occurred on April 13, 1919, and it remains a watershed moment in India’s journey to political freedom from the British Raj. Historian Nonica Datta, who teaches in JNU, ...
- Study on need for close monitoring for heart riskon April 26, 2021 at 4:01 am
According to an American Heart Association scientific statement the hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart ...
- Computer-based image analysis of atherosclerosis in the carotid arteryon April 22, 2021 at 5:00 pm
In a recent study published in Arteriosclerosis, Thrombosis and Vascular Biology, Andrew Buckler, Ph.D. student in Ulf Hedin's research group Vascular Surgery, Department of Molecular Medicine and ...
- Arteriosclerosis Testers Market Research Report by Type, by Distribution Channel – Global Forecast to 2025 – Cumulative Impact of COVID-19on April 6, 2021 at 12:04 pm
Apr 06, 2021 (Heraldkeepers) -- The global Arteriosclerosis Testers market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World.
- Global Arteriosclerosis Therapeutics Market 2020 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2025on March 10, 2021 at 5:34 pm
Mar 10, 2021 (CDN Newswire via Comtex) -- An up to date report titled Global Arteriosclerosis Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024 released by ...
via Bing News